Lidocaine Pain Relief Gel -Patch
NDC 83602-185, Lidocaine, patch, from Guangzhou Liuquanmiao Import & Export Trade Co., Ltd..
- Product NDC
- 83602-185
- Status
- Listed
- Labeler
- Guangzhou Liuquanmiao Import & Export Trade Co., Ltd.
- Dosage form
- PATCH
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- 505G(a)(3)
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83602-185 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIDOCAINE.04 g/g
Pharmacologic classes
Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83602-185-08 | 83602018508 | 8 BAG in 1 BOX (83602-185-08) / 1 PATCH in 1 BAG / 21 g in 1 PATCH (83602-185-01) |
| 83602-185-09 | 83602018509 | 9 BAG in 1 BOX (83602-185-09) / 1 PATCH in 1 BAG / 21 g in 1 PATCH (83602-185-01) |
| 83602-185-10 | 83602018510 | 10 BAG in 1 BOX (83602-185-10) / 1 PATCH in 1 BAG / 21 g in 1 PATCH (83602-185-01) |
| 83602-185-11 | 83602018511 | 11 BAG in 1 BOX (83602-185-11) / 1 PATCH in 1 BAG / 21 g in 1 PATCH |
| 83602-185-12 | 83602018512 | 12 BAG in 1 BOX (83602-185-12) / 1 PATCH in 1 BAG / 21 g in 1 PATCH |
| 83602-185-17 | 83602018517 | 17 BAG in 1 BOX (83602-185-17) / 1 PATCH in 1 BAG / 21 g in 1 PATCH |
| 83602-185-18 | 83602018518 | 18 BAG in 1 BOX (83602-185-18) / 1 PATCH in 1 BAG / 21 g in 1 PATCH |
| 83602-185-23 | 83602018523 | 23 BAG in 1 BOX (83602-185-23) / 1 PATCH in 1 BAG / 21 g in 1 PATCH |
| 83602-185-24 | 83602018524 | 24 BAG in 1 BOX (83602-185-24) / 1 PATCH in 1 BAG / 21 g in 1 PATCH |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 83602-185 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83602-185 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83602-185. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.